293 related articles for article (PubMed ID: 28702092)
1. PAT-H-MS coupled with laser microdissection to study histone post-translational modifications in selected cell populations from pathology samples.
Noberini R; Longuespée R; Richichi C; Pruneri G; Kriegsmann M; Pelicci G; Bonaldi T
Clin Epigenetics; 2017; 9():69. PubMed ID: 28702092
[TBL] [Abstract][Full Text] [Related]
2. Pathology Tissue-quantitative Mass Spectrometry Analysis to Profile Histone Post-translational Modification Patterns in Patient Samples.
Noberini R; Uggetti A; Pruneri G; Minucci S; Bonaldi T
Mol Cell Proteomics; 2016 Mar; 15(3):866-77. PubMed ID: 26463340
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in mass spectrometry analysis of histone post-translational modifications: potential clinical impact of the PAT-H-MS approach.
Bonaldi T; Noberini R
Expert Rev Proteomics; 2016; 13(3):245-50. PubMed ID: 26822344
[TBL] [Abstract][Full Text] [Related]
4. Mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the PAT-H-MS approach.
Noberini R; Pruneri G; Minucci S; Bonaldi T
Data Brief; 2016 Jun; 7():188-94. PubMed ID: 27408908
[TBL] [Abstract][Full Text] [Related]
5. [Extraction and isolation of histones from paraffin-embedded tissues and quantitative analysis of post-translational modifications].
Tian S; Liu R; Qian X; Guo X; Zhang K
Se Pu; 2021 Oct; 39(10):1094-1101. PubMed ID: 34505431
[TBL] [Abstract][Full Text] [Related]
6. PAT-ChIP coupled with laser microdissection allows the study of chromatin in selected cell populations from paraffin-embedded patient samples.
Amatori S; Ballarini M; Faversani A; Belloni E; Fusar F; Bosari S; Pelicci PG; Minucci S; Fanelli M
Epigenetics Chromatin; 2014; 7():18. PubMed ID: 25104973
[TBL] [Abstract][Full Text] [Related]
7. A Super-SILAC Strategy for the Accurate and Multiplexed Profiling of Histone Posttranslational Modifications.
Noberini R; Bonaldi T
Methods Enzymol; 2017; 586():311-332. PubMed ID: 28137569
[TBL] [Abstract][Full Text] [Related]
8. Spatial epi-proteomics enabled by histone post-translational modification analysis from low-abundance clinical samples.
Noberini R; Savoia EO; Brandini S; Greco F; Marra F; Bertalot G; Pruneri G; McDonnell LA; Bonaldi T
Clin Epigenetics; 2021 Jul; 13(1):145. PubMed ID: 34315505
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometry-based characterization of histones in clinical samples: applications, progress, and challenges.
Noberini R; Robusti G; Bonaldi T
FEBS J; 2022 Mar; 289(5):1191-1213. PubMed ID: 33415821
[TBL] [Abstract][Full Text] [Related]
10. Enrichment of histones from patient samples for mass spectrometry-based analysis of post-translational modifications.
Noberini R; Restellini C; Savoia EO; Bonaldi T
Methods; 2020 Dec; 184():19-28. PubMed ID: 31605746
[TBL] [Abstract][Full Text] [Related]
11. SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells.
Cuomo A; Moretti S; Minucci S; Bonaldi T
Amino Acids; 2011 Jul; 41(2):387-99. PubMed ID: 20617350
[TBL] [Abstract][Full Text] [Related]
12. Alternative digestion approaches improve histone modification mapping by mass spectrometry in clinical samples.
Restellini C; Cuomo A; Lupia M; Giordano M; Bonaldi T; Noberini R
Proteomics Clin Appl; 2019 Jan; 13(1):e1700166. PubMed ID: 30471193
[TBL] [Abstract][Full Text] [Related]
13. MALDI Imaging Combined with Laser Microdissection-Based Microproteomics for Protein Identification: Application to Intratumor Heterogeneity Studies.
Longuespée R; Alberts D; Baiwir D; Mazzucchelli G; Smargiasso N; De Pauw E
Methods Mol Biol; 2018; 1788():297-312. PubMed ID: 29224050
[TBL] [Abstract][Full Text] [Related]
14. Epigenomic profiling of archived FFPE tissues by enhanced PAT-ChIP (EPAT-ChIP) technology.
Amatori S; Persico G; Paolicelli C; Hillje R; Sahnane N; Corini F; Furlan D; Luzi L; Minucci S; Giorgio M; Pelicci PG; Fanelli M
Clin Epigenetics; 2018 Nov; 10(1):143. PubMed ID: 30446010
[TBL] [Abstract][Full Text] [Related]
15. Accelerating the Field of Epigenetic Histone Modification Through Mass Spectrometry-Based Approaches.
Lu C; Coradin M; Porter EG; Garcia BA
Mol Cell Proteomics; 2021; 20():100006. PubMed ID: 33203747
[TBL] [Abstract][Full Text] [Related]
16. The contribution of mass spectrometry-based proteomics to understanding epigenetics.
Noberini R; Sigismondo G; Bonaldi T
Epigenomics; 2016 Mar; 8(3):429-45. PubMed ID: 26606673
[TBL] [Abstract][Full Text] [Related]
17. Probing Glioblastoma Tissue Heterogeneity with Laser Capture Microdissection.
Gagner JP; Zagzag D
Methods Mol Biol; 2018; 1741():209-220. PubMed ID: 29392703
[TBL] [Abstract][Full Text] [Related]
18. [Laser microdissection and mass spectrometry based proteomics in the diagnosis of kidney diseases].
Sun Y; Li M; Wen Y; Li X; Sun J; Sun W
Sheng Wu Gong Cheng Xue Bao; 2014 Jul; 30(7):1134-40. PubMed ID: 25345014
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Pattern of hPTMs by Mass Spectrometry-Based Proteomics with Implications for Triple-Negative Breast Cancer.
Liu C; Xu M; Li W; Cao X; Wang Y; Chen H; Zhang T; Lu M; Xie H; Chen Y
J Proteome Res; 2024 Apr; 23(4):1495-1505. PubMed ID: 38576392
[TBL] [Abstract][Full Text] [Related]
20. Characterization of histone-related chemical modifications in formalin-fixed paraffin-embedded and fresh-frozen human pancreatic cancer xenografts using LC-MS/MS.
Bauden M; Kristl T; Andersson R; Marko-Varga G; Ansari D
Lab Invest; 2017 Mar; 97(3):279-288. PubMed ID: 27941757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
